Measuring heart fat with AI improves cardiovascular risk prediction

Mayo Clinic research identified a powerful new way to improve the prediction of a patient’s long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI). Heart disease develops over time and remains the leading cause of death worldwide, so identifying risk early is critical to preventing heart attack, stroke and other serious outcomes. … Read more

Rethinking cardiovascular risk assessment in women

Less artery-clogging plaque in women’s arteries did not appear to protect them from heart disease compared to men, according to a study published in Circulation: Cardiovascular Imaging, an American Heart Association journal. While heart disease is the leading cause of illness and death in the U.S. and worldwide, according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics, women … Read more

Why lung cancer in never smokers is rising and how targeted detection could reduce deaths

Researchers reveal why lung cancer in people who never smoked is increasing and explore how genetics, environmental exposures, and new screening strategies may help detect disease earlier and improve outcomes. Opinion: Lung cancer in never smokers: from early detection to prevention. Image Credit: Thx4Stock team / Shutterstock In a recent opinion piece published in the … Read more

Guide Helps Assess Child Abuse–Related Head Injury

The Child and Youth Maltreatment Section of the Canadian Paediatric Society (CPS) has released a new Practice Point for the assessment of children with suspected traumatic head injury related to child maltreatment (THI-CM). This type of injury “is not rare and frequently results in significant morbidity for the child and family,” the CPS told Medscape … Read more

Sorry Fido, The eNose Can Smell ILD Subtypes Too

SAN FRANCISCO — Dogs trained to sniff out lung disease may need to look for another line of work if an “electronic nose” sensor in development makes it into widespread clinical practice. In a multicenter cohort study of 589 patients with a diagnosis of interstitial lung disease (ILD) by multidisciplinary team discussion and evidence of … Read more

COPD Diagnosis Reboot Identifies More At-Risk Individuals

SAN FRANCISCO — A new diagnostic schema incorporating chest CT and respiratory symptoms into the diagnosis of chronic obstructive pulmonary disease (COPD) can help to better identify patients at risk for poor respiratory outcomes and rule out those with airflow obstruction who have neither respiratory symptoms nor evidence of structural lung disease. The recommendation for … Read more

Psittacosis pneumonia with the reversed halo sign: a case report and literature review | BMC Infectious Diseases

To identify other cases of psittacosis pneumonia with the RHS reported between 2003 and 2023, and to clarify the clinical features of this disease, we searched the PubMed, Embase, and Web of Science databases using the keywords (“psittacosis” OR “Chlamydia psittaci” OR “psittacosis pneumonia”) AND (“reversed halo sign” OR “atoll sign” OR “CT”). We identified … Read more

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

For the majority of patients at high-risk for biochemical recurrence of prostate cancer (PCa), new prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) research reaffirms a lack of sustained efficacy for monotherapy treatment with local radiation therapy or radical prostatectomy. For the retrospective study, recently published in BJUI Compass, researchers reviewed PSMA PET/CT data … Read more

Diagnostic Imaging's Weekly Scan: May 4 — May 10 – diagnosticimaging.com

Diagnostic Imaging’s Weekly Scan: May 4 — May 10  diagnosticimaging.com Source link

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

Emerging research suggests that hormone therapy has no significant impact upon the diagnostic efficacy of 18F-piflufolastat PET/CT for detecting recurrent or metastatic prostate cancer. For the retrospective study, recently published in The Prostate, researchers evaluated the use of 18F-piflufolastat PET/CT (Pylarify, Lantheus) in 93 patients with elevated prostate-specific antigen (PSA) levels and suspected local recurrence … Read more